# Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy

> **NCT01976923** · PHASE3 · COMPLETED · sponsor: **J. Fernando Arevalo, MD FACS** · enrollment: 224 (actual)

## Conditions studied

- Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy

## Interventions

- **DRUG:** Intravitreal bevacizumab
- **PROCEDURE:** Small-gauge pars plana vitrectomy

## Key facts

- **NCT ID:** NCT01976923
- **Lead sponsor:** J. Fernando Arevalo, MD FACS
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2018-07
- **Final completion:** 2018-10
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2018-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01976923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01976923, "Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01976923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*